These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 38730340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 3. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE.
    Hemoglobin; 2024 May; 48(3):169-174. PubMed ID: 38980121
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE.
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [Abstract] [Full Text] [Related]

  • 7. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 8. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A.
    Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
    [Abstract] [Full Text] [Related]

  • 9. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R.
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S, Mtei L, Soka D, Mdai V, Mwakale PB, Mrosso P, Mchoropa I, Rwezaula S, Azayo M, Ulenga N, Ngido M, Cox SE, D'Mello BS, Masanja H, Kabadi GS, Mbuya F, Mmbando B, Daniel Y, Streetly A, Killewo J, Tluway F, Lyimo M, Makani J.
    Int Health; 2019 Nov 13; 11(6):589-595. PubMed ID: 31145786
    [Abstract] [Full Text] [Related]

  • 12. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L.
    Pediatr Blood Cancer; 2019 May 13; 66(5):e27657. PubMed ID: 30724025
    [Abstract] [Full Text] [Related]

  • 13. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS, Briscoe C, Muhongo M, Pascoal R, Armando A, Santos B, McGann PT.
    Blood Adv; 2023 Oct 10; 7(19):5860-5867. PubMed ID: 37399450
    [Abstract] [Full Text] [Related]

  • 14. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A, Cisse Z, Keita I, Desmonde S, Sarro YDS, Touré BA, Baraika MA, Tessougué O, Guindo P, Coulibaly M, Traore O, Sylla N, Diassana M, Saye A, Picot V, Lauressergues E, Leroy V.
    Br J Haematol; 2024 Jan 10; 204(1):337-345. PubMed ID: 37728227
    [Abstract] [Full Text] [Related]

  • 15. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update.
    Kasai ET, Gulbis B, Ntukamunda JK, Bours V, Batina Agasa S, Marini Djang'eing'a R, Boemer F, Katenga Bosunga G, Ngbonda Dauly N, Sokoni Vutseme J, Boso Mokili B, Alworong'a Opara JP.
    Hematology; 2023 Dec 10; 28(1):2213043. PubMed ID: 37183964
    [Abstract] [Full Text] [Related]

  • 16. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
    Nguyen-Khoa T, Mine L, Allaf B, Ribeil JA, Remus C, Stanislas A, Gauthereau V, Enouz S, Kim JS, Yang X, Gluckman E, Beaudeux JL, Munnich A, Girot R, Cavazzana M.
    Ann Biol Clin (Paris); 2018 Aug 01; 76(4):416-420. PubMed ID: 29976532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Newborn screening for sickle cell disease in France].
    Brousse V, Allaf B, Benkerrou M.
    Med Sci (Paris); 2021 May 01; 37(5):482-490. PubMed ID: 34003094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.